Skip to main content

Home/ Cerebral Palsy/ Group items tagged hydroxyprogesterone caproate and multiple births

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Lee Vander Loop

17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triple... - 0 views

www.clinicaltrials.gov/...NCT00163020

drug study twin and triplet pregnancies hydroxyprogesterone caproate and multiple births clinical trial clinical trials 17OHP progesterone study research

shared by Lee Vander Loop on 28 May 10 - Cached
  • Lee Vander Loop on 28 May 10
     
    Hypothesis of study is that among women with twin or triplet pregnancies, weekly injections of 17-alpha-hydroxyprogesterone caproate (17OHP), started before 24 weeks of gestation, will reduce neonatal morbidity by reducing the rate of preterm delivery.This study involves two concurrent double-blinded randomized clinical trials of 17OHP versus placebo. Each trial will test the efficacy and safety of 17OHP in women with a specific risk factor for preterm birth. The two risk factors to be studied are: Twin pregnancy - Triplet pregnancy
1 - 1 of 1
Showing 20▼ items per page